US warns monkeypox could mutate to resist antiviral drug

In an online update, FDA officials cautioned that a single molecular change to monkeypox "could have a large impact on the antiviral activity of Tpoxx." Since viruses are constantly evolving to overcome obstacles to infection, including drugs, regulators stressed that doctors should be "judicious" in prescribing the medication.

from World News Headlines, Latest International News, World Breaking News - Times of India https://ift.tt/nYlPC4U